Continuous Coverage Makeup
NDC 49527-010
Product Information
Continuous Coverage Makeup is a OTC MONOGRAPH NOT FINAL-approved product labeled by Clinique Laboratories Inc. This product is primarily utilized in pharmaceutical processing or compounding. It is supplied as a product. This product entry covers the primary NDC 49527-010 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 49527-010?
What are the uses of this product?
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- WATER (UNII: 059QF0KO0R)
- TALC (UNII: 7SEV7J4R1U)
- BUTYLENE GLYCOL (UNII: 3XUS85K0RA)
- ISOSTEARIC ACID (UNII: X33R8U0062)
- GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4)
- PEG-100 STEARATE (UNII: YD01N1999R)
- PHENYL TRIMETHICONE (UNII: DR0K5NOJ4R)
- MAGNESIUM ALUMINUM SILICATE (UNII: 6M3P64V0NC)
- TROMETHAMINE (UNII: 023C2WHX2V)
- CHOLESTEROL (UNII: 97C5T2UQ7J)
- SODIUM ALGINATE (UNII: C269C4G2ZQ)
- CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)
- CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)
- HYALURONATE SODIUM (UNII: YSE9PPT4TH)
- TRIETHYL CITRATE (UNII: 8Z96QXD6UM)
- LECITHIN, SOYBEAN (UNII: 1DI56QDM62)
- STEARIC ACID (UNII: 4ELV7Z65AP)
- ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)
- POLYAMINOPROPYL BIGUANIDE (UNII: 322U039GMF)
- PHENOXYETHANOL (UNII: HIE492ZZ3T)
- MICA (UNII: V8A1AW0880)
- IRON (UNII: E1UOL152H7)
- BISMUTH OXYCHLORIDE (UNII: 4ZR792I587)
* Please review the full disclaimer at the bottom of this page.